《大行報告》里昂:小米(01810.HK)季績勝預期 評級升至「買入」上望19.7元
里昂發表報告指,小米(01810.HK)第三季季績勝於預期,總收入按年升0.6%至709億元人民幣,勝於預期,經調整淨利潤按年升183%至60億元人民幣,勝於預期。智能手機交付量呈正增長,並在新興市場表現強勁及成功於內地實現高端化。物聯網(IoT)銷售大部分受到家電推動,同時網絡收入受惠海外廣告。
小米集團毛利率創歷史新高,受惠產品組合改善。該行預料此趨勢或持續下去,估計小米第四收入或按年升11%,調整後淨利潤則按年升180%。
該行表示,將小米今年及明年調整後淨利潤預測分別上調5%及15%,其目標價則由19元上調至19.7元,其評級則由「跑贏大市」升至「買入」。(ca/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.